Predicting Low Density Lipoprotein-cholesterol Receptor Gene Mutations Using Lipid Profiles in Young Adults With Suspected Familial Hypercholesterolemia
The Journal of the korean Military Medicine · 2025
DOI: 10.64416/jkmm.56.1.56 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of the korean Military Medicine, 2025. Verfasst von Changin Han und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Objective
Familial hypercholesterolemia (FH) is the most common autosomal dominant monogenic disorder and a significant contributor to premature cardiovascular disease. Despite its clinical importance, FH is frequently underdiagnosed, particularly in young adults with limited access to family history or follow-up. This study aimed to evaluate lipid profile-based predictors for low-density lipoprotein receptor (LDLR) gene mutations in young military personnel undergoing genetic testing for suspected FH.
Method
We conducted a retrospective analysis of 111 individuals with clinical suspicion of familial hypercholesterolemia (FH) who underwent LDLR genetic testing between March 2022 and December 2023 at a Korean military hospital. Clinical parameters―including low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), triglycerides (TG), and body mass index (BMI)―were compared based on mutation status. Logistic regression and receiver operating characteristic (ROC) curve analyses were performed to determine optimal cut-off values using the Youden index.
Results
LDLR mutations were identified in 26 individuals (23.4%). The mutation-positive group had significantly higher LDL-C levels than the mutation-negative group (232.5 ± 58.8 vs. 197.6 ± 40.9 mg/dL, p = 0.008). The ROC analysis for LDL-C yielded an area under the curve (AUC) of 0.698, with an optimal threshold of 218.9 mg/dL (sensitivity 53.8%, specificity 85.9%). A multivariate model incorporating LDL-C, HDL-C, TG, and BMI improved the AUC to 0.711 (cut-off probability 0.29; sensitivity 53.8%, specificity 89.4%).
Conclusion
An LDL-C threshold of 218.9 mg/dL may serve as a practical criterion for identifying candidates for LDLR gene testing among young adults with clinically suspected FH. A multivariate lipid-based approach may further improve the accuracy of FH screening, especially in military or resource-limited clinical settings.
Zitieren
APA
Han, C., & Lee, J. (2025). Predicting Low Density Lipoprotein-cholesterol Receptor Gene Mutations Using Lipid Profiles in Young Adults With Suspected Familial Hypercholesterolemia. The Journal of the korean Military Medicine. https://doi.org/10.64416/jkmm.56.1.56
Vancouver
Han C, Lee J. Predicting Low Density Lipoprotein-cholesterol Receptor Gene Mutations Using Lipid Profiles in Young Adults With Suspected Familial Hypercholesterolemia. The Journal of the korean Military Medicine. 2025. doi:10.64416/jkmm.56.1.56
BibTeX
@article{Han2025,
author = {Han, Changin and Lee, Jaejun},
title = {Predicting Low Density Lipoprotein-cholesterol Receptor Gene Mutations Using Lipid Profiles in Young Adults With Suspected Familial Hypercholesterolemia},
journal = {The Journal of the korean Military Medicine},
year = {2025},
doi = {10.64416/jkmm.56.1.56}
}
EUVIMED